244 related articles for article (PubMed ID: 22184406)
1. Mouse NK cell-mediated rejection of bone marrow allografts exhibits patterns consistent with Ly49 subset licensing.
Sun K; Alvarez M; Ames E; Barao I; Chen M; Longo DL; Redelman D; Murphy WJ
Blood; 2012 Feb; 119(6):1590-8. PubMed ID: 22184406
[TBL] [Abstract][Full Text] [Related]
2. Increased bone marrow allograft rejection by depletion of NK cells expressing inhibitory Ly49 NK receptors for donor class I antigens.
Raziuddin A; Longo DL; Bennett M; Winkler-Pickett R; Ortaldo JR; Murphy WJ
Blood; 2002 Oct; 100(8):3026-33. PubMed ID: 12351417
[TBL] [Abstract][Full Text] [Related]
3. Contrasting effects of anti-Ly49A due to MHC class I cis binding on NK cell-mediated allogeneic bone marrow cell resistance.
Alvarez M; Sungur CM; Ames E; Anderson SK; Pomeroy C; Murphy WJ
J Immunol; 2013 Jul; 191(2):688-98. PubMed ID: 23752612
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effects of in vivo depletion of Ly-49A and Ly-49G2 natural killer cell subsets in the rejection of H2(b) bone marrow cell allografts.
Raziuddin A; Bennett M; Winkler-Pickett R; Ortaldo JR; Longo DL; Murphy WJ
Blood; 2000 Jun; 95(12):3840-4. PubMed ID: 10845918
[TBL] [Abstract][Full Text] [Related]
5. Ly49I NK cell receptor transgene inhibition of rejection of H2b mouse bone marrow transplants.
Liu J; Morris MA; Nguyen P; George TC; Koulich E; Lai WC; Schatzle JD; Kumar V; Bennett M
J Immunol; 2000 Feb; 164(4):1793-9. PubMed ID: 10657626
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets.
Raziuddin A; Longo DL; Mason L; Ortaldo JR; Bennett M; Murphy WJ
J Immunol; 1998 Jan; 160(1):87-94. PubMed ID: 9551959
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the NK cell alloreactivity to bone marrow cells by the combination of the host NK gene complex and MHC haplotypes.
Iizuka K; Scalzo AA; Xian H; Yokoyama WM
J Immunol; 2008 Mar; 180(5):3260-7. PubMed ID: 18292550
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
[TBL] [Abstract][Full Text] [Related]
9. Ly49-dependent NK cell licensing and effector inhibition involve the same interaction site on MHC ligands.
Choi T; Ferris ST; Matsumoto N; Poursine-Laurent J; Yokoyama WM
J Immunol; 2011 Apr; 186(7):3911-7. PubMed ID: 21335486
[TBL] [Abstract][Full Text] [Related]
10. Positive recognition of MHC class I molecules by the Ly49D receptor of murine NK cells.
George TC; Mason LH; Ortaldo JR; Kumar V; Bennett M
J Immunol; 1999 Feb; 162(4):2035-43. PubMed ID: 9973475
[TBL] [Abstract][Full Text] [Related]
11. MHC class I recognition by NK receptors in the Ly49 family is strongly influenced by the beta 2-microglobulin subunit.
Michaëlsson J; Achour A; Rölle A; Kärre K
J Immunol; 2001 Jun; 166(12):7327-34. PubMed ID: 11390483
[TBL] [Abstract][Full Text] [Related]
12. Role of classical (RT1.A) and nonclassical (RT1.C) MHC class I regions in natural killer cell-mediated bone marrow allograft rejection in rats.
Engh E; Benestad HB; Strøm-Gundersen I; Vaage JT; Bell EB; Rolstad B
Transplantation; 1998 Feb; 65(3):319-24. PubMed ID: 9484746
[TBL] [Abstract][Full Text] [Related]
13. Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection.
Held W; Cado D; Raulet DH
J Exp Med; 1996 Nov; 184(5):2037-41. PubMed ID: 8920892
[TBL] [Abstract][Full Text] [Related]
14. Perforin- and Fas-dependent mechanisms of natural killer cell-mediated rejection of incompatible bone marrow cell grafts.
Taylor MA; Ward B; Schatzle JD; Bennett M
Eur J Immunol; 2002 Mar; 32(3):793-9. PubMed ID: 11870623
[TBL] [Abstract][Full Text] [Related]
15. Altered donor and recipient Ly49+ NK cell subsets in allogeneic H-2d --> H-2b and H-2b --> H-2d bone marrow chimeras.
Korten S; Wilk E; Gessner JE; Meyer D; Schmidt RE
J Immunol; 1999 Dec; 163(11):5896-905. PubMed ID: 10570275
[TBL] [Abstract][Full Text] [Related]
16. NK cell tolerance in mixed allogeneic chimeras.
Zhao Y; Ohdan H; Manilay JO; Sykes M
J Immunol; 2003 Jun; 170(11):5398-405. PubMed ID: 12759414
[TBL] [Abstract][Full Text] [Related]
17. The immunobiology of natural killer cells and bone marrow allograft rejection.
Barao I; Murphy WJ
Biol Blood Marrow Transplant; 2003 Dec; 9(12):727-41. PubMed ID: 14677112
[TBL] [Abstract][Full Text] [Related]
18. Class I MHC-binding characteristics of the 129/J Ly49 repertoire.
Makrigiannis AP; Pau AT; Saleh A; Winkler-Pickett R; Ortaldo JR; Anderson SK
J Immunol; 2001 Apr; 166(8):5034-43. PubMed ID: 11290784
[TBL] [Abstract][Full Text] [Related]
19. The activating Ly49W and inhibitory Ly49G NK cell receptors display similar affinities for identical MHC class I ligands.
Ma BJ; Craveiro Salvado CM; Kane KP
Immunogenetics; 2014 Aug; 66(7-8):467-77. PubMed ID: 24797174
[TBL] [Abstract][Full Text] [Related]
20. Ly-49 G2+ NK cells are responsible for mediating the rejection of H-2b bone marrow allografts in mice.
Raziuddin A; Longo DL; Mason L; Ortaldo JR; Murphy WJ
Int Immunol; 1996 Dec; 8(12):1833-9. PubMed ID: 8982767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
